B cell development in bone marrow (BM)
3 follows ordered cellular stages and proceeds through sequential rearrangement of Ig H and L chain genes. The recombinases, RAG1 and RAG2, first mediate H chain gene rearrangement at the pro-B cell stage to produce a functional H chain and then mediate L chain gene rearrangement at the small pre-BII cell stage to produce a or L chain. H and L chains assemble with the Ig␣-Ig␤ heterodimer to form a B cell Ag receptor (BCR) complex on the cell surface. BCR ϩ immature B cells are immediately subject to Ag-mediated negative selection events including apoptosis (central deletion), anergy, or secondary gene rearrangement (receptor editing) to eliminate harmful autoreactive clones. Recent studies (1) (2) (3) suggest that receptor editing is the predominant mechanism of negative selection. For cells expressing autoreactive BCRs, encounter with Ag triggers a BCR signal leading to a 2-h delay in development and increased expression of Rag1 and Rag2 genes (1) . Subsequent cleavage at the recombination signal sequence (RSS) of L chain loci results in rearrangement of a new L chain, which assembles with the H chain to form a new BCR with reduced autoreactivity. Only those immature B cells that succeed in passing these tests of negative selection exit the BM and continue to differentiate in the periphery.
In the periphery, the newly immigrated immature B cells, termed transitional 1 (T1) cells, pass through phenotypically distinct transitional stages before they are selected into one of the three mature B cell pools: follicular (FO) B2, marginal zone (MZ), and B1 B subsets (4, 5) . A ligand-independent BCR tonic signal is essential for B cell survival and maturation from the transitional to the FO stage (6) . Tonic signals are affected by the level of BCR expression, the activity of accessory molecules, such as CD19 and CD22, and secondary messengers of the BCR signaling pathway (revewed in Ref. 7) . Changes in the expression or function of these molecules are found to affect the development of mature B cells (7) . In contrast to FO B2 cell differentiation, MZ, and B1 B cell differentiation requires a ligand-dependent signal (8) . The strength of this signal is critical, because strong ligand-mediated BCR signals can induce negative selection such as anergy or deletion (9, 10) . Whether receptor editing in transitional B cells normally occurs is uncertain. Although receptor editing in mature and germinal center B cells is well documented, these studies were conducted under special circumstances, such as immunization, ongoing autoimmune responses, or in cells with mutant BCR signaling molecules (11) (12) (13) (14) (15) . This type of peripheral receptor editing, also known as "receptor revision", is purported to generate high-affinity Abs rather than to silence autoreactive B cell clones.
We have generated V H 12V1A H and L chain transgenic (Tg) mice (designated 6 -1/V1A) to study Ag-mediated positive and negative selection mechanisms (16, 17) . B cells expressing the 6 -1/V1A BCR are developmentally blocked at the transitional 2 (T2) cell stage with no evidence of Ag-imposed negative regulation. These cells are short lived, express high levels of BCRs, proliferate, and secrete Abs normally in response to a variety of stimuli, and most importantly, differentiate into B2-like cells following treatment with a low dose anti-Ig␤ Ab in vivo (17) . Furthermore, 6 -1/V1A transitional B cells are sensitive to cell death induced by a high-dose anti-Ig␤ Ab in vivo. We attributed this developmental arrest to a lack of a ligand-mediated positive selection signal.
In this report, we used low doses of anti-Ig␤ Ab to mimic Ag stimulation and compared receptor editing in immature and transitional B cells from 6 -1/V1A Tg and normal non-Tg mice. Our results demonstrated that in response to anti-Ig␤ stimulation, immature B cells underwent RAG-mediated receptor editing but transitional B cells did not, even though they increased RAG expression. Instead, transitional B cells underwent differentiation to a more mature B cell.
Materials and Methods
Mice V H 12 Tg (6 -1), 6 -1/V1A, 6 -1/V1A/RAG1 Ϫ/Ϫ , and 6 -1/V4 Tg mice have been previously described (17, 18) . CB17 mice were purchased from Taconic Farms. All mice were kept under specific pathogen-free conditions. All animal protocols were approved by the University of North Carolina Institutional Animal Care and Use Committee and the National Institute of Allergy and Infectious Diseases Animal Care and Use Committee.
Abs and other reagents
mAbs for flow cytometry were purchased from BD Biosciences. Fluorescence-encapsulated liposomes was made previously (18) . PMA was purchased from Sigma-Aldrich. Ionomycin was obtained from Molecular Probes (Invitrogen Life Technologies). Anti-Ig␤ Ab (clone HM79) was described previously (17) .
Flow cytometry, cell purification, and treatment protocols
Bone marrow and splenic cells were stained with fluorochrome-labeled Abs and analyzed on a FACSCalibur (17) (5, 17, 19) . The purity of sorted cells was Ͼ90%. For in vitro culture experiments, BM and splenic B cells were purified by negative selection using a Mouse B cell Recovery Column kit (Cedarlane Laboratories) or magnetic-activated Dynal beads (Invitrogen Life Technologies). Cells were cultured with RPMI 1640 medium supplemented with 10% FBS and antibiotics. Stimulants, including anti-Ig␤ mAb (0.1-10 g/ml), PMA (2 ng/ml), and ionomycin (2 ng/ml), were added to cultures for 24 h. For cell cycle analysis, the cells were fixed with 70% ethanol overnight, treated with RNase (100 g/ml) plus propidium iodide (50 g/ml) and analyzed by flow cytometry.
For in vivo treatment, 6 -1/V1A mice were injected i.p. with a single dose of 10 g of anti-Ig␤ Ab or normal hamster IgG for 5 days. BM and spleen cells were prepared for cell sorting as described above.
Ligation-mediated (LM)-PCR
DNA was purified from cells using a DNeasy Tissue kit (Qiagen) according to the manufacturer's instructions. The linker ligation and PCR conditions have been described previously (20 -22) . In brief, 2 g of genomic DNA was ligated with the BW linker and 100 ng of ligated DNA was amplified for 12 cycles with the linker primer BW-1 and a locus-specific primer VS, followed by an additional 27 cycles with BW-1 and a nested locus-specific primer. The PCR products were analyzed by electrophoresis in 1.2% agarose gels and transferred to a nylon membrane (Bio-Rad). The blots were hybridized with 32 P-labeled locus-specific internal oligonucleotides and analyzed with the Storm Phosphorimager using ImageQuant software (Molecular Dynamics). To control for the amount of amplifiable DNA in each sample, 5 l of ligated DNA was amplified for 27 cycles under the identical conditions with the primers CD14L and CD14R to amplify the CD14 gene.
Analysis of RAG expression
Quantification of Rag1 and Rag2 transcripts was performed by real time quantitative PCR (qPCR). Total RNA was isolated using a RNeasy Mini kit (Qiagen). Approximately 200 ng of total RNA in 20 l was reverse-transcribed with SuperScript II reverse transcriptase and random hexamer primers (Invitrogen Life Technologies). The PCR was performed in an ABI Prism 7000 and 9000 Sequence Detection Systems with the SYBR Green PCR Master Mix reagents (Applied Biosystems). The cDNAs were serially diluted (50/10/5/1) to check the efficiency of the PCR to amplify Rag1, Rag2, and the house keeping gene hypoxanthine phosphoribosyltransferase (Hprt). PCR primer sequences were: Rag1 forward, 5Ј-GAAATTCAA-CACCCACAAATCAAA-3Ј; Rag1 reverse, 5Ј-TTCTAGGTAAGGTTTC-CCCTCTGA-3Ј; Rag2 forward, 5Ј-CAGTCTTGCCAGGAGGAATCTC-3Ј; Rag2 reverse, 5Ј-ACAAGGCTGCAGACCATCCTT-3Ј; Hprt forward, 5Ј-GTTCTTTGCTGACCTGCTGGAT-3Ј; Hprt reverse, 5Ј-GTCCCCC-GTTGACTGATCAT-3Ј. Quantification was performed relative to the expression levels of non-Tg pre-B cells.
The expression of RAG2 proteins in anti-Ig␤-stimulated B cells was detected by immunoblotting. In brief, proteins extracted from equal amount of cells were subjected for SDS-PAGE and transferred to PVDF membranes using standard procedures. The membranes were blocked with 4% BSA and probed with Abs against RAG2 (Santa Cruz Biotechnology), followed by HRP-conjugated secondary Ab. Immunoreactive proteins were detected by using the ECL kit (Amersham Biosciences). The films were scanned and the density of protein bands were quantitated by using Image J software (http://rsb.info.nih.gov/ij).
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed using a ChIP assay kit purchased from Millipore. In brief, BM cells from 6 -1/V1A mice were cultured with IL-7 for 5 days followed by 18 h without IL-7. The cells were then harvested and cultured with and without 1 g/ml anti-Ig␤ Ab for 18 h. Splenic cells from 6 -1/V1A mice were similarly cultured with 1 g/ml anti-Ig␤ Ab for 18 h. The cells were then stained with Abs reacting with B220-PE plus IgM a -FITC or B220-PE plus liposome for BM and spleen cultures, respectively, and sorted for B220
ϩ IgM ϩ and B220 ϩ liposome Ϫ B cells, respectively. The cells were cross-linked by addition of 1% formaldehyde for 15 min at room temperature. Cells were lysed in SDS lysis buffer and sonicated using an optimized condition to shear DNA to lengths between 200 and 1000 bp. The lysates were precleared with 80 l of salmon sperm DNA/protein A agarose-50% slurry followed by incubation with anti-acetyl-histone H3 or anti-trimethy-histone H3-K4 Abs (Millipore). The immune complexes were recovered by salmon sperm DNA/protein A agarose and washed extensively. The DNA was recovered and real-time PCR was performed to amplify Jk5 and Tcra. The primers were: Jk5, forward, 5Ј-GGATCG-GAGAATAAGCATGAGTAGTTA-3Ј, reverse, 5Ј-TTCCTCATCCCCT-CCAAATCT-3Ј; Tcra constant region, forward, 5Ј-CGACTGCTGTTT-GCCAAGAC-3Ј, reverse, 5Ј-AGGGTGAAGCTGGGAATATGAA-3Ј.
Results

-1/V1A B cells arrest at a transitional B cell stage
In the BM of 6 -1/V1A Tg mice, almost all IgM ϩ B cells are B220 low , a phenotype consistent with that of immature B cells (Fig. 1 ). In the spleen, ϳ10% of B cells were specific for phosphatidyl choline (PtC), detected using liposomes with membrane incorporated PtC. These cells expressed the B1 cell markers CD5 and CD43 ((16) and our unpublished data), suggesting that they are B1 cells. These PtC ϩ B cells expressed endogenous L chains, predominantly the V4/5H gene required for PtC binding (16) . Consistent with our previous report (17) , the majority of the PtC Ϫ B cells were CD21 Ϫ , CD23 Ϫ/low , and IgM high , resembling a transitional B cell phenotype (Fig. 1) . On a RAG1-deficient background, the splenic B cells of 6 -1/V1A mice were exclusively T1 and T2 cells (17) . The lack of mature B cells in the periphery may account for the absence of mature recirculating B cells in the BM (Fig. 1) . Thus, 6 -1/V1A B cells were unable to develop into mature B2 cells, but could become B1 cells through expression of an endogenous L chain.
Expression of endogenous L chains by some B cells of 6 -1/ V1A mice is indicative of incomplete L chain allelic exclusion. Similar "leakiness" of allelic exclusion has been observed in other L chain-targeted mice (23) . To rule out Ag-induced secondary L chain gene rearrangement in 6 -1/V1A mice, we determined the levels of Rag1 and Rag2 transcripts and the generation of dsDNA break (DSB) at RSS of J loci. As shown in Fig 
Immature but not transitional B cells of 6 -1/V1A mice undergo receptor editing in response to low dose anti-Ig␤ stimulation
To determine whether transitional B cells can edit in response to a BCR signal, we stimulated immature and transitional B cells of 6 -1/V1A Tg mice with anti-Ig␤ Ab or PMA plus ionomycin (P.I.) for 24 h in vitro. PMA activates protein kinase C leading to activation of the MAP kinase cascade, a major signaling pathway downstream of the BCR, whereas ionomycin triggers a calcium signal that bypasses the BCR to induce receptor editing in immature B cells (24) . Because RAG proteins are sensitive to cell cycling, low concentrations of PMA and ionomycin (1-5 ng/ml) were used to minimize their effect on cell cycle. Under these conditions, cell survival and growth were not changed (Fig. 3) . AntiIg␤ Ab was also used at a low concentration (1 g/ml) to maintain normal viability. Under these culture conditions, the viability of the cells was ϳ80% as determined by staining with propidium iodide (Fig. 3) or Annexin V (data not shown). LM-PCR analyses of 6 -1/V1A immature B cells revealed that anti-Ig␤ treatment induced an increase in DSB at J2 and J5, whereas P.I. induced an increase in J5 DSB and a modest increase in J2 DSB (Fig.  4A) . Neither treatment had an effect on transitional B cells (Fig.  4A ). Note that, although levels varied from mouse to mouse, a longer film exposure revealed that there were more DSB in untreated immature than in transitional B cells ( Figs. 2A and 4A ). We also observed that DSB were induced in immature B cells with as little as 0.1 g/ml anti-Ig␤ Ab (data not shown). This result supports the idea that the signaling threshold for receptor editing is set very low in immature B cells. Surprisingly, anti-Ig␤ treatment of 6 -1/V1A immature B cells failed to stimulate RAG expression (Fig. 4 , B and C). By contrast, both RAG2 mRNA and protein were slightly increased in anti-Ig␤-treated transitional B cells (Fig.  4 , B and C). Despite the absence of significant changes in RAG expression, RAG activity in anti-Ig␤ treated immature B cells was significantly increased as assessed by the production of RSS breaks. Although treatment with P.I. did not alter RAG expression in immature B cells, it induced a significant down-regulation of RAG expression in transitional B cells (Fig. 4B) , indicating differential responses of RAG expression to P.I. stimulation between the cells of these two subsets. The up-regulation of RAG expression in 6 -1/V1A transitional B cells was not due to contamination with a small number of PtC ϩ B cells, because anti-Ig␤ stimulation of PtC ϩ B cells from V H 12 H chain only Tg mice downregulated RAG expression (data not shown). Thus, failure of transitional B cells to initiate RAG-mediated L chain gene rearrangement following stimulation with either anti-Ig␤ or P.I. suggests that they have lost the ability to undergo receptor editing.
To verify this result in vivo, we injected 6 -1/V1A mice i. (17) . For BM immature B cells, treatment with anti-Ig␤ induced a slight down-regulation of surface IgM and a reduction in the number of IgM ϩ cells (Fig. 5 ), which could be explained by a delayed generation of immature B cells, deletion in immature B cells, or migration of immature B cells to the spleen. The observation that treatment with anti-Ig␤ Ab at the higher concentration of 10 g/ml did not induce apoptosis in vitro (Fig. 3) argues against induced deletion. However, 100 g anti-Ig␤ Ab did induce deletion (17) .
To determine whether anti-Ig␤ induces DSB in transitional B cells, we sorted PtC Ϫ IgM low CD23 ϩ and PtC Ϫ IgM high B cells from the spleen and BM immature B cells, and measured DSB at J RSS sites. As shown in Fig. 4D , anti-Ig␤ treatment induced DSB in 
Transitional B cells of non-Tg normal mice fail to edit in response to low dose anti-Ig␤ stimulation
To determine whether normal transitional B cells can be induced to edit, we purified and stimulated transitional B cells from non-Tg mice that had received sublethal irradiation (500 rads) 14 days earlier. Spleens of these mice are highly enriched for T1 and T2 cells (17, 25) . Consistent with the findings with 6 -1/V1A transitional B cells, treatment of non-Tg transitional B cells with antiIg␤ Ab or P.I. did not induce an increase in DSB at J RSS sites, although they did induce increased RAG expression (Fig. 4, E and  F) . We, therefore, conclude that both 6 -1/V1A and non-Tg transitional B cells are resistant to anti-Ig␤-induced receptor editing, even using concentrations of anti-Ig␤ 10-fold higher than that required to induce receptor editing in immature B cells.
BM stromal cells do not support receptor editing in transitional B cells
Monroe and colleagues have shown that a Thy1 dull DX5 ϩ stromal BM cell population can redirect Ag-induced B cell apoptosis to receptor editing (26, 27) . To determine whether BM stromal cells can promote anti-Ig␤-induced receptor editing in 6 -1/V1A transitional B cells, we cocultured purified transitional B cells with BM cells isolated from RAG1 Ϫ/Ϫ mice. Under these conditions, treatment with anti-Ig␤ Ab failed to induce DSB in transitional B cells, although it did induce DSB in immature B cells (Fig. 6A) . However, the levels of RAG transcripts increased in both cell types (Fig. 6B) . We obtained the same result with purified transitional B cells from sublethally irradiated normal mice (Fig. 6, C and D) . The failure to induce editing in 6 -1/V1A and normal transitional B cells could not be ascribed to a loss of the Thy1 dull DX5 ϩ cell population, because it was readily identified by flow cytometry (Fig. 6E) . The increased RAG expression in normal antiIg␤-treated transitional B cells was consistent with previous reports using anti-IgM Abs (26, 27) . However, unlike anti-Ig␤, antiIgM did not induce DSB unless cells were prevented from undergoing apoptosis (26) . Based on propidium iodide staining, a concentration of 1 g/ml (used in this study) or 10 g/ml antiIg␤ Ab did not cause apoptosis (Fig. 3) , whereas 10 g/ml anti-IgM Ab readily induced apoptosis (Fig. 3) . We conclude that anti-Ig␤-stimulated transitional B cells are unable to undergo efficient L chain receptor editing, even in the presence of BM stromal cells.
The levels of histone H3 acetylation and trimethylation on lysine4 (K4) are comparable between immature and transitional B cells
Chromatin remodeling regulates V(D)J rearrangements through progressive stages of early B cell development (28) . High levels of histone H3 acetylation and methylation on K4 are associated with an open chromatin structure for the recombination machinery (29, 30) . To determine the level of acetyl-H3 and methyl-H3-K4 at J gene segments, we performed ChIP assays using cross-linked DNA from 6 -1/V1A immature and transitional B cells and Abs against acetylated H3 and trimethylated H3-K4. After cross-linking was reversed, the J5 sequence was amplified by real time PCR. As shown in Fig. 7 , the levels of acetyl-H3 at J5, calculated as the percentage of input DNA, were comparable between resting transitional B cells (27.7%) and immature B cells (15.5%). The levels of trimethyl-H3-K4 at J5 were also similar between the two subsets (transitional B cells, 7.5%, vs immature B cells, 7.8%). These levels were equivalent to those in pre-BII cells in which an open chromatin structure at J loci is expected. After stimulation with anti-Ig␤ Ab, the levels of acetyl-H3 and trimethyl-H3-K4 at J5 increased in both subpopulations. Transitional B cells appear to have higher levels of acetyl-H3 (59.2%) than immature B cells (32.5%) even though the difference was statistically insignificant. As a negative control, the levels of acetyl-H3 and trimethyl-H3-K4 at the TCR␣ locus were very low (Յ0.1%, Fig. 7 ), consistent with a "closed" locus. We conclude from these data that the J gene loci of transitional B cells are likely to be accessible for RAG recombination. This parallels the open chromatin structure seen at Ig V H loci in mature B cells (31) .
Immature and transitional B cells exhibit distinct phenotypic changes following BCR ligation
Treatment with PMA (2 ng/ml) stimulated increased expression of CD23 on transitional but not on immature B cells (Fig. 8) . In addition, PMA-activated transitional cells exhibited a decrease in IgM and HSA expression as well as an increase in CD21 expression (Fig. 8) . Fewer immature B cells underwent these changes. These phenotypic changes were consistent with alterations seen after in vivo anti-Ig␤ injection ( 
Discussion
These experiments demonstrate that transitional B cells lose the capacity for receptor editing in response to a BCR signal. This differs from immature B cells that undergo BCR ligation-triggered secondary L chain gene rearrangements in response to the same treatment. Interestingly, the capacity for receptor editing is not correlated with RAG expression levels; whereas there was no significant change in RAG expression, either at the RNA or protein levels in anti-Ig␤-treated immature B cells, the expression levels of RAGs were increased considerably in anti-Ig␤-treated transitional B cells. Thus, caution should be used in interpreting increases in RAG levels. The 6 -1/V1A B cell development is blocked at the T2 cell stage (17) . Phenotypical and functional analyses have failed to reveal any difference between 6 -1/V1A and normal transitional B cells (17) . The presence of B cells expressing endogenous L chains in BM immature B cells of 6 -1/V1A mice is most likely due to a "premature" expression of L chains in early (CD43 ϩ ) B cells (32, 33) than to self-Ag-induced receptor editing. We are currently unable to rule out the possibility that the 6 -1/V1A BCR is unable to generate sufficient tonic signaling to complete L chain allelic exclusion and mature B cell differentiation. However, several findings are inconsistent with weak tonic signaling. First, 6 -1/ V1A B cells express normal levels of surface BCR and elicit normal levels of protein tyrosine phosphorylation following BCR cross-linking (17) . Second, insufficient tonic signaling would most likely result in frequent endogenous L chain rearrangement in pre-BII/immature B cells, rather than in just a few cells (Fig. 2) . Third, Shivtiel et al. (34) have demonstrated that the loss of CD19 induces an increase in receptor editing due to the failure of the BCR to provide an effective tonic signal. This predicts that if the defect in 6 -1/V1A B cells is a lack of tonic signaling, then reducing the level of CD19 should have no effect on DSB and RAG expression. However, the BM immature B cells of 6 -1/V1A/CD19 ϩ/Ϫ mice with the expression level of CD19 reduced by 50% exhibited a 5-fold increase in RAG expression and more abundant DSB at J2 and J4 loci compared with 6 -1/V1A/CD19 ϩ/ϩ mice (data not shown). CD19 deficiency also failed to promote B cell maturation beyond the T2 cell stage (data not shown). Thus, the 6 -1/V1A BCR provides a tonic signal that is sufficient to block receptor editing in the bone marrow.
Receptor editing plays a critical role in shaping the Ab repertoire. It is estimated that 25-50% of developing immature BM B cells undergo receptor editing (1, 3, 35, 36) . Earlier studies with mice bearing conventional transgenes to MHC class I show that receptor editing occurs in IgM low but not in IgM high immature B cell populations (24) . However, studies using more physiologically relevant Ig gene knockin mice suggest that editing occurs in pre-BII cells rather than in immature B cells (37) . This observation has been extended by Casellas et al. (1) showing that editing at the pre-BII cell stage causes 2-h delay in the transition from pre-BII to immature B. In contrast to these findings, Tze et al. (38) demonstrated that both IgM low and IgM high immature B cells undergo receptor editing when stimulated with soluble HEL. Thus, when receptor editing occurs during B cell differentiation is in dispute. It may be dependent on the nature of the Ag and the location of Ag encounter. Even though our study did not distinguish between IgM low and IgM high immature B cells, our data are consistent with the conclusion that receptor editing can occur in immature BM B cells.
In the spleen, transitional B cells are either positively selected into the long-lived mature B cell pool or die by negative selection mechanisms including deletion (apoptosis) and negligence (lack of positive selection). Evidence for peripheral deletion comes from studies using Tg mice expressing BCRs for a liver-expressed autoantigen with high affinity (9) . In this setting, cross-linking BCRs on transitional B cells results in apoptosis in vitro (10, 39) . These studies indicate that transitional B cells are as sensitive as BM immature B cells to BCR-mediated apoptosis. Our recent studies have shown that the development of 6 -1/V1A B cells is blocked at a T2 cell stage without evidence of Ag-imposed negative selection (17) . Interestingly, injection of 6 -1/V1A/Rag1 Ϫ/Ϫ mice with a high dose of anti-Ig␤ Ab induced apoptosis while a low dose of anti-Ig␤ induced differentiation as assessed by the expression of maturation markers and longer survival of treated B cells in vitro (17) . This model argues that "negligence" or lack of a ligandmediated positive selection signal may account for the death of The role of receptor editing in development of transitional B cells is poorly understood. The levels of RAG1 and RAG2 expression drop drastically when immature B cells become transitional B cells (Fig. 2 and Ref. 40, 41) . This is consistent with an inability of transitional B cells to edit. It is surprising that expression of RAG can be reinduced when transitional B cells receive a BCR signal (Fig. 4 and Ref. 26 ), yet DNA rearrangement does not occur (Fig. 4) . Thus, the mechanism preventing editing in transitional B cells does not involve regulation of RAG protein levels. Control of editing could be due to multiple mechanisms. First, transitional B cells may be unable to survive stimulation strong enough to induce editing. This possibility is supported by a previous study in which an anti-apoptotic agent was used to facilitate anti-IgM-induced receptor editing (26) . Second, the comparable levels of histone H3 acetylation and trimethylation at Lys4 on J5 between immature and transitional B cells argue against a "closed" chromatin structure in transitional B cells. However, if RAG proteins are functional, there may be other levels of histone modification that prevent RAG access to J genes. In addition, our results suggested that the differing response of immature and transitional B cells to BCR stimulation could be due to distinct signaling networks. Such differences also exist even among transitional B cells (42) . The expression level of mitogen-and stress-activated kinase 2 (MSK2) is Ͼ6-fold higher in transitional B cells than in immature B cells (data not shown). MSK2 is involved in phosphorylation of histone H3 at Ser (10) and Ser (28) (43) . The increased expression of MSK2 and possibly other signaling molecules in transitional B cells may induce secondary modification of histones leading to decreased accessibility of Ig loci.
Third, the activity of RAG proteins may be differently regulated by phosphorylation and/or ubiquitinylation in immature and transitional B cells. The discrete domains outside the recombinase-core region of RAGs are potential regulatory structures that can be phosphorylated (44) and ubiquitinylated (45) . Because the levels of RAG transcripts and proteins were comparable between immature and transitional B cells (Fig. 2 and Fig. 4) , modification of RAG proteins by either of these two mechanisms would reduce recombinase activity and prevent secondary gene rearrangements. Future studies are warranted to clarify these issues.
The suggestion that transitional B cells are unable to edit does not conflict with other studies in which receptor editing was found in periphery lymphoid organs of mice undergoing immunization or during an autoimmune response (11) (12) (13) (14) . Under those conditions, non-BCR signals, such as cytokines, may override the recombination restraining mechanism found in transitional B cells and activate V(D)J recombination fully. Because stimulation of circulating B cells (including transitional and mature B cells) with a bacterial Ag, Staphylococcus aureus Cowan I, plus IL-2 induces expression of RAG and L chain gene rearrangement (46) , it is also possible that receptor editing in peripheral B cells could occur through a BCR-independent mechanism. This may account for receptor editing found in germinal center B cells (11, 21) .
Why do transitional B cells develop such a restriction mechanism to prevent recombination? We speculate that this may be of biological importance for preserving genetic stability and reducing susceptibility to RAG-mediated lymphomagenesis. More importantly, this mechanism may prevent emergence of dual L chain-expressing B cells. We reason that if receptor editing is permissible in transitional B cells, dual receptor-expressing B cells would be more frequently produced due to the increased sensitivity of transitional B cells to Ag-mediated positive selection. In view of our previous findings that low concentrations of anti-Ig␤ Ab induced differentiation of transitional B cells and high concentrations induced apoptosis (17), we conclude that although transitional B cells are limited in receptor editing, they remain sensitive to other positive and negative selection mechanisms. 
